期刊文献+

系统性红斑狼疮伴血液系统损害的临床研究 被引量:11

Systemic lupus erythematosus complicating with hematological disorders
原文传递
导出
摘要 目的观察系统性红斑狼疮(SLE)血液系统损害的特征,探讨其临床意义。方法 145例确诊的SLE患者被纳入研究,分为贫血组、免疫性血小板减少性紫癜(ITP)组、白细胞减少组、对照组(无血液系统改变的SLE)四组。所有患者均接受常规血液学及免疫学检查,部分患者行骨髓检查。结果 113例(77.9%)SLE患者有血液学异常,贫血88例(60.7%),贫血的主要类型有慢性疾病性贫血(ACD)37例(42.0%)、缺铁性贫血(IDA)29例(33.0%)、自身免疫性溶血性贫血(AIHA)15例(17.0%)、其他7例(8.0%);白细胞减少46例(31.7%),<3.0×109/L14例;血小板减少57例(39.3%);无血液学异常32例(22.1%)。SLE并发AIHA的肾损伤发生率及SLE疾病活动指数(SLEDAI)较对照组高(P<0.05);AIHA组dsDNA、AnuA抗体、抗心磷脂抗体(ACL)的阳性率较对照组高(P<0.05),而C3明显降低(P<0.05)。42例患者行骨髓检查,36例增生活跃,6例增生低下;5例有骨髓细胞形态异常。结论 SLE并发血液系统损害多见,以贫血最为常见,其可能不仅与ACL等抗体诱导的外周成熟红细胞破坏有关,还与铁代谢紊乱导致的骨髓红系造血细胞功能异常有关;AIHA可能是SLE出现肾损害的危险因素,并可作为疾病活动的评判指标;血小板减少与巨核细胞成熟障碍有关。骨髓造血细胞受累亦可能是SLE并发血细胞损害的原因。 Objective To study the characteristics of hematological abnormalities in patients with systemic lupus erythematosus (SLE) and their associations with immunological and clinical parameters.Methods One hundred and forty-five consecutive SLE patients were enrolled into the study.The patients were divided into 4 groups:anemia group,low white blood cell group,immune thrombopenic purpura group and control group (SLE patients without hematological abnormalities).Standard hematological and immunological tests were performed in all participants and the examination of bone marrow was performed in 42 patients.Results 77.9% of pSS patients had hematological abnormalities.The prevalence of leucocytopenia,anemia and thrombocytopenia were 31.7% (46 /145),60.7% (88 /145) and 39.3% (57 /145) respectively.SLE patients with anemia included ACD 37 (42%),IDA 29 (33%),AIHA 15 (17%) and other reasons 7 (8%).The prevalence of renal involvement was much higher in SLE patients with AIHA or WBC 〈 3.0 × 109 /L than that in control group (P 〈 0.05),respectively.SLE patients with AIHA presented anti-dsDNA,AnuA,ACL antibodies increased while level of C3 reduced compared with control group (P 〈 0.05,respectively).Abnormal bone marrow changes were observed in 5 SLE patients with morphological changes.Conclusions Hematological abnormalities are common in SLE patients,of which anemia is the most common findings.Cytopenia might be related to not only the damages of mature cell mediated by autoantibodies (such as ACL etc),but also impaired red cells production because of iron metabolic disturbance;SLE with AIHA may be a risk factor of renal involvement,and thrombocytopenia was related to the functional impairment of megakaryocyte in producing plate.Bone marrow involvement may be another reason of SLE patients with hematological disorders.
出处 《中华临床医师杂志(电子版)》 CAS 2010年第9期88-93,共6页 Chinese Journal of Clinicians(Electronic Edition)
关键词 红斑狼疮 系统性 贫血 血小板减少 白细胞减少 骨髓疾病 Lupus erythematosus,systemic; Anemia; Thrombocytopenia; Leukopenia; Bone marrow diseases;
  • 相关文献

参考文献19

  • 1Gladman DD,Ibanez D,Urowitz MB.Systemic lupus erythematosus disease activity index 2000.J Rheumatol,2002,29(2):288-291.
  • 2Al Arfaj AS,Khalil N.Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia.Lupus,2009,18(5):465-473.
  • 3AlSaleh J,Jassim V,EISayed M,et al.Clinical and immunological manifestations in 151 SLE patients living in Dubai.Lupus,2008,17(1):62-66.
  • 4张幼莉,张学武,贺联印.系统性红斑狼疮相关性血液学异常[J].临床内科杂志,1998,15(3):160-161. 被引量:28
  • 5陈嘉林,黄晓明,曾学军,王玉,周明晓,马亚辉,李蓉生,沈悌.系统性红斑狼疮患者血液学异常的特点及其临床意义[J].中华医学杂志,2007,87(19):1330-1333. 被引量:19
  • 6Font J,Cervera R,Ramos-Casals M,et al.Clusters of clinical and immunologic features in systemic lupus erythemalosus:analysis of 600 patients from a single center.Semin Arthritis Rheum,2004,33(4):217-230.
  • 7Voulgarefis M,Kokori SI,loannidis JP,et al.Anaemia in systemic lupus erythematosus:aetiological profile and the role of erythropuietin.Ann Rheum Dis,2000,59(3):217-222.
  • 8Hammond A,audge AC,Loizou S.et al.Reduced numbers of complement receptor type l on erythrocytes are associated with increased levels of anticardiolipin antibodies.Findings in patients with systemic lupus erythematosus and the antiphospholipid syndrome.Arthritis Rheum,1989,32(3):259-64.
  • 9Kasitanon N,Magder LS,Petri M.Predictors of survival in systemic lupus erythematosus.Medicine(Baltimore),2006,85(3):147-156.
  • 10Means RT Jr,Dessypfis EN,Krantz SB.Inhibition of human erythroid colony-forming units by interleukin-1 is mediated by gamma interferon.J Cell Physid,1992,150(1):59-64.

二级参考文献14

  • 1陈嘉林,李淑兰,徐闽,王海滨,葛昌文,李蓉生.血清转铁蛋白受体对贫血患者鉴别诊断的临床意义[J].中华内科杂志,2004,43(6):423-425. 被引量:12
  • 2李蓉生.慢性病贫血//张之南,沈悌,主编.血液病诊断及疗效标准.2版.北京:科学出版社,1998:30-33.
  • 3Font J, Cervera R, Ramos-Casals M, et al. Clusters of Clinical and Features in Systemic lupus erythematosus: Analysis of 600 patients from a single center. Semin Arthritis Rheum, 2004,33: 217 -230.
  • 4Hoohberg MC, Boyd RE , Ahearn JM, et al. Systemic lupus erythematosus : a review of Clinico-laboratory feature and immunogenetic markers in 150 patients with emphasis on demographic subets . Medicine, 1985,64:285-295.
  • 5Voulgarelis M, Kokori SIG, Ioannidis JAP, et al. Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin. Ann Rheum Dis, 2000, 59: 217-222.
  • 6Keeling DM, Isonberg DA. Hematological manifestations of systemic lupus erythematosus. Blood Reviews, 1993, 7: 199- 207.
  • 7Pistiner M ,Wallace DJ ,Nessim S,et al. Lupus erythematosus in the 1980s: a Survey of 570 patients . Semin Arthritis Rheum, 1991, 21:55-64.
  • 8Kasitanon N, Magder LS, Petri M. Predictors of survival in systemic lupus erythematosus. Medicine, 2006, 85:147-156.
  • 9Matsugama W, Yamamoto M, Higashimoto I, et al. TNF-related apoptosis-inducing ligand is involved in neutropenia of systemic lupus erythematosus. Blood, 2004,104 : 184-191.
  • 10Chen M ,Zhao M H,Zhang Y,et al. Antineutrophil autoantibodies and their target antigens in systemic lupus erythematosus. Lupus, 2004, 13:584-589.

共引文献45

同被引文献109

引证文献11

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部